InvestorsHub Logo
Followers 18
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: None

Friday, 11/16/2018 3:27:32 PM

Friday, November 16, 2018 3:27:32 PM

Post# of 713358
Were looking at $1-$2 billion in revenue the first year after approval. Unmet need in GBM. My guess is that there will be immediate demand to study the effects in other brain tumors and finish a P3 for solid tumors, along with combo trials with checkpoint inhibitors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News